John R Burnett Selected Research

Apolipoproteins B (ApoB)

6/2016	Lipoprotein metabolism in an apoB-80 familial hypobetalipoproteinemia heterozygote.
5/2016	Novel APOB missense variants, A224T and V925L, in a black South African woman with marked hypocholesterolemia.
11/2015	Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia.
10/2014	Novel missense MTTP gene mutations causing abetalipoproteinemia.
6/2013	Non-alcoholic steatohepatitis-related cirrhosis in a patient with APOB L343V familial hypobetalipoproteinaemia.
1/2012	Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia.
2/2011	Mipomersen, an antisense apolipoprotein B synthesis inhibitor.
1/2011	Familial hypercholesterolemia: epidemiology, Neolithic origins and modern geographic distribution.
4/2008	Familial hypobetalipoproteinemia in a Turkish family with hereditary spastic paraplegia.
3/2008	High-resolution melting analysis for detection of familial ligand-defective apolipoprotein B-100 mutations.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John R Burnett Research Topics

Disease

19	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2002
16	Atherosclerosis 01/2020 - 05/2002
12	Hypercholesterolemia 01/2018 - 03/2003
12	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 06/2016 - 04/2003
11	Coronary Artery Disease (Coronary Atherosclerosis) 07/2022 - 10/2004
11	Coronary Disease (Coronary Heart Disease) 06/2014 - 02/2004
10	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 10/2019 - 08/2007
9	Hyperlipidemias (Hyperlipidemia) 10/2016 - 09/2002
4	Hypertension (High Blood Pressure) 07/2022 - 02/2004
4	Hypertriglyceridemia 10/2016 - 07/2006
4	Abetalipoproteinemia (Bassen Kornzweig Syndrome) 11/2015 - 07/2006
3	Obesity 07/2022 - 07/2006
3	Tangier Disease 01/2020 - 06/2004
3	Pancreatitis 04/2017 - 12/2009
3	Inborn Genetic Diseases (Disease, Hereditary) 11/2015 - 11/2007
3	Phenylketonurias (Phenylketonuria) 02/2015 - 11/2007
3	Insulin Resistance 01/2015 - 02/2004
3	Dyslipidemias (Dyslipidemia) 01/2015 - 10/2004
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2010 - 02/2004
3	Xanthomatosis (Xanthoma) 12/2009 - 02/2008
2	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2021 - 07/2006
2	Wolman Disease (Wolman's Disease) 01/2018 - 12/2008
2	Hypothyroidism 04/2017 - 11/2006
2	Infections 01/2016 - 09/2009
2	Homozygous Familial Hypercholesterolemia 01/2015 - 02/2011
2	Type 2 Diabetes Mellitus (MODY) 02/2007 - 02/2004
1	Respiratory Tract Infections (Respiratory Tract Infection) 04/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021
1	Rare Diseases (Rare Disease) 06/2020
1	Pathologic Constriction (Stenosis) 01/2020
1	Genetic Risk Score 01/2018
1	Proteinuria 10/2017
1	Type E Brachydactyly 04/2017
1	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 11/2016
1	Lipase deficiency combined 10/2016
1	Abscess 01/2016
1	Renal Insufficiency (Renal Failure) 12/2015
1	Failure to Thrive 11/2015
1	Steatorrhea 11/2015
1	Hypersplenism (Anemia, Splenic) 09/2014
1	Type B Niemann-Pick Disease 09/2014
1	Alcoholic Fatty Liver 06/2013
1	Fibrosis (Cirrhosis) 06/2013
1	Injection Site Reaction 01/2012

Drug/Important Bio-Agent (IBA)

26	LDL CholesterolIBA 10/2019 - 07/2006
19	Apolipoproteins B (ApoB)IBA 06/2016 - 04/2003
15	LipidsIBA 02/2021 - 05/2002
15	ApolipoproteinsIBA 02/2019 - 04/2003
15	Lipoproteins (Lipoprotein)IBA 06/2016 - 04/2003
14	LDL Lipoproteins (beta Lipoproteins)IBA 05/2017 - 04/2008
10	CholesterolIBA 12/2020 - 05/2002
9	Lipoprotein(a)IBA 07/2022 - 02/2011
7	HDL CholesterolIBA 02/2019 - 02/2004
6	oxidized low density lipoproteinIBA 01/2018 - 02/2008
5	Triglycerides (Triacylglycerol)IBA 04/2022 - 02/2004
5	Apolipoprotein B-100 (Apo B 100)IBA 01/2011 - 10/2004
4	LDL Receptors (LDL Receptor)IBA 07/2022 - 10/2004
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2006
4	Apolipoproteins E (ApoE)IBA 01/2018 - 06/2004
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2015 - 05/2002
4	Phenylalanine (L-Phenylalanine)FDA Link 02/2015 - 11/2007
4	Pharmaceutical PreparationsIBA 11/2006 - 07/2006
3	CalciumIBA 01/2020 - 09/2009
3	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 10/2016 - 12/2009
3	EnzymesIBA 09/2014 - 09/2005
3	mipomersenIBA 01/2012 - 10/2006
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2016 - 06/2004
2	ChylomicronsIBA 10/2016 - 01/2015
2	Vitamin E FDA LinkGeneric 11/2015 - 07/2006
2	O(4)-methylthymidine triphosphateIBA 01/2015 - 10/2014
2	microsomal triglyceride transfer proteinIBA 01/2015 - 07/2006
2	AcidsIBA 09/2014 - 09/2006
2	Proprotein Convertase 9IBA 06/2014 - 08/2007
2	LigandsIBA 03/2008 - 10/2004
2	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 02/2008 - 11/2007
2	alpha-Tocopherol FDA Link 01/2008 - 07/2006
2	Acyl Coenzyme A (Acyl CoA)IBA 03/2003 - 09/2002
1	Fibronectins (Fibronectin)IBA 07/2022
1	Asparaginase (Elspar)FDA Link 12/2021
1	Sebelipase alfaIBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 10/2017
1	Blood Proteins (Serum Proteins)IBA 10/2017
1	Thyroxine (Levothyroxine)FDA LinkGeneric 04/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2016
1	EstersIBA 10/2016
1	Lipase (Acid Lipase)FDA Link 10/2016
1	CreatinineIBA 12/2015
1	VitaminsIBA 11/2015
1	Retinaldehyde (Retinal)IBA 11/2015
1	Dietary Fats (Dietary Fat)IBA 11/2015
1	Mixed Function Oxygenases (Monooxygenases)IBA 02/2015
1	VLDL LipoproteinsIBA 01/2015
1	BMS201038IBA 01/2015
1	neodymium pyrocatechin disulfonate (NPD)IBA 09/2014
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 09/2014
1	AngiopoietinsIBA 07/2014
1	anacetrapibIBA 01/2012

Therapy/Procedure

12	Therapeutics 02/2021 - 07/2006
1	Enzyme Replacement Therapy 01/2018
1	Blood Component Removal (Apheresis) 06/2014